Disclosures for "Adapted Machine Learning to Map Outpatient Neurological Conditions from a Large United Kingdom Urban Conurbation, between 2018 and 2024. "
-
Dr. Markey has nothing to disclose.
-
Dr. Ahmed has nothing to disclose.
-
Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Novartis. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
-
Dr. Silverdale has nothing to disclose.
-
Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Mr. Lilleker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro.
-
Dr. Mohanraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharma.